References

Alleva DG, Kaser SB, Monroy MA, Fenton MJ, Beller DI (1997) IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol. 159:2941-2951 Ameglio F, D'Auria L, Cordiali-Fei P, Trento E, D'Agosto G, Mastroianni A, Giannetti A, Giacalone B (1999) Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients with Pemphigus vulgaris relationships with peripheral blood neutrophil counts, disease severity and duration and patients' age. J Biol Regul Homeost Agents 13:220-224 Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH (1995) IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154:483-490 Arnold R, Seifert M, Asadullah K, Volk HD (1999) Crosstalk between ker-atinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. J Immunol 162:7140-7147 Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA (1994) The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A 91:4940-4944 Baslund B et al. (2004) 0P0008; EULAR 2003, Ann Rheum Dis (in press) Bernard J, Harb C, Mortier E, Quemener A, Meloen RH, Vermot-Desroches C, Wijdeness J, van Dijken P, Grotzinger J, Slootstra JW, Plet A, Jacques Y (2004) Identification of an interleukin-15alpha receptor-binding site on human interleukin-15. J Biol Chem 279:24313-24322 Budagian V, Bulanova E, Orinska Z, Ludwig A, Rose-John S, Saftig P, Borden EC, Bulfone-Paus S (2004a) Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17). J Biol Chem 279:40368-40375 Budagian V, Bulanova E, Orinska Z, Pohl T, Borden EC, Silverman R, Bulfone-Paus S (2004b) Reverse signaling through membrane-bound interleukin-15. J Biol Chem 279:42192-42201 Castagnoli C, Trombotto C, Ariotti S, Millesimo M, Ravarino D, Magliacani G, Ponzi AN, Stella M, Teich-Alasia S, Novelli F, Musso T (1999) Expression and role of IL-15 in post-burn hypertrophic scars. J Invest Dermatol 113:238-245

Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB (2001) Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 357 (9271):1842-1847 Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, Park SH, Kim HY (2004) Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis Rheum 50:776-784 Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB (2000) Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 43:1244-1256 Dubois S, Mariner J, Waldmann TA, Tagaya Y (2002) IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 17:537-547 Fehniger TA, Caligiuri MA (2001) Interleukin 15: biology and relevance to human disease. Blood 97:14-32 Ferrari-Lacraz S, Zheng XX, Kim YS, Li Y, Maslinski W, Li XC, Strom TB (2001) An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol 167:3478-3485 Girard D, Boiani N, Beaulieu AD (1998) Human neutrophils express the interleukin-15 receptor alpha chain (IL-15Ralpha) but not the IL-9Ralpha component. Clin Immunol Immunopathol 88:232-240 Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM (1995) Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 14:3654-3663 Gonzalez-Alvaro I, Ortiz AM, Garcia-Vicuna R, Balsa A, Pascual-Salcedo D, Laffon A (2003) Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease. Clin Exp Rheumatol 21:639-642 Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG (1994) Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965-968

Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 100:9452-9457 Hessian PA, Highton J, Kean A, Sun CK, Chin M (2003) Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Arthritis Rheum 48:334-338

Kanegane H, Tosato G (1996) Activation of naive and memory T cells by interleukin-15. Blood 88:230-235

Kim YS, Maslinski W, Zheng XX, Stevens AC, Li XC, Tesch GH, Kelley VR, Strom TB (1998) Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol 160:5742-5748

Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martin Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 363:675-681 Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB, Etanercept Psoriasis Study Group (2003) Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349:2014-2022 McInnes IB, Gracie JA (2004) Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 392-397 McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 3:189-195 McInnes IB, Leung BP, Liew FY (2000) Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells. Arthritis Res 2:374378

McInnes IB, Gracie JA, Harnett M, Harnett W, Liew FY (2003) New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis 62 [Suppl 2]:ii51-54 Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etaner-cept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356(9227):385-390 Mohamadzadeh M, Takashima A, Dougherty I, Knop J, Bergstresser PR, Cruz PD Jr (1995) Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. J Immunol 155:4492-4496 Mori A, Suko M, Kaminuma O, Inoue S, Ohmura T, Nishizaki Y, Nagahori T, Asakura Y, Hoshino A, Okumura Y, Sato G, Ito K, Okudaira H (1996) IL-15 promotes cytokine production of human T helper cells. J Immunol 156:2400-2405

Mortier E, Bernard J, Plet A, Jacques Y (2004) Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist. J Immunol 173:1681-1688 Musso T, Calosso L, Zucca M, Millesimo M, Ravarino D, Giovarelli M, Malavasi F, Ponzi AN, Paus R, Bulfone-Paus S (1999) Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 93:3531-3539

Neely GG, Epelman S, Ma LL, Colarusso P, Howlett CJ, Amankwah EK, McIn-tyre AC, Robbins SM, Mody CH (2004) Monocyte surface-bound IL-15 can function as an activating receptor and participate in reverse signaling. J Immunol 172:4225-4234 Nickoloff BJ, Bonish B, Huang BB, Porcelli SA (2000) Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci 24 :212-225 Nieto M, del Pozo MA, Sanchez-Madrid F (1996) Interleukin-15 induces adhesion receptor redistribution in T lymphocytes. Eur J Immunol 26:1302-1307 Nishimura H, Hiromatsu K, Kobayashi N, Grabstein KH, Paxton R, Sugamura K, Bluestone JA, Yoshikai Y (1996) IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection. J Immunol 156:663669

Ogata Y, Kukita A, Kukita T, Komine M, Miyahara A, Miyazaki S, Kohashi O(1999) A novel role of IL-15 in the development of osteoclasts inability to replace its activity with IL-2. J Immunol 162:2754-2760 Ong PY, Hamid QA, Travers JB, Strickland I, Al Kerithy M, Boguniewicz M, Leung DY (2002) Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol 168):505-510 Perera L, Waldmann T (1999) IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J Immunol 162:2606-2612 RapplG, Kapsokefalou A, HeuserC, RosslerM, UgurelS, TilgenW, ReinholdU, Abken H (2001) Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha. J Invest Dermatol 116):102-109 Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY (1998) Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 160:5654-5660 Ruckert R, Herz U, Paus R, Ungureanu D, Pohl T, Renz H, Bulfone-Paus S (1998) IL-15-IgG2b fusion protein accelerates and enhances a Th2 but not a Th1 immune response in vivo, while IL-2-IgG2b fusion protein inhibits both. Eur J Immunol 28:3312-3320 Ruckert R, Asadullah K, Seifert M, Budagian VM, Arnold R, Trombotto C, Paus R, Bulfone-Paus S (2000) Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol 165:22402250

Seder RA, Grabstein KH, Berzofsky JA, McDyer JF (1995) Cytokine interactions in human immunodeficiency virus-infected individuals: roles of inter-leukin (IL)-2, IL-12, and IL-15. J Exp Med 182:1067-1077

Seder RA (1996) High-dose IL-2 and IL-15 enhance the in vitro priming of naive CD4+ T cells for IFN-gamma but have differential effects on priming for IL-4. J Immunol 156:2413-2422 Taylor PC, Williams RO, Maini RN (2001) Immunotherapy for rheumatoid arthritis. CurrOpin Immunol 13:611-616 Treiber-Held S, Stewart DM, Kurman CC, Nelson DL (1996) IL-15 induces the release of soluble IL-2Ralpha from human peripheral blood mononuclear cells. Clin Immunol Immunopathol 79:71-78 Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, Skov L, Rygaard J, Voorhorst-Ogink MM, Gerritsen AF, van Dijk MA, Parren PW, Baadsgaard O, van de Winkel JG (2003) Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 112:1571-1580

Waldmann TA, Tagaya Y (1999) The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 17:19-49 Waldmann T, Tagaya Y, Bamford R (1998) Interleukin-2, interleukin-15, and their receptors. Int Rev Immunol 16:205-226 Wilkinson PC, Liew FY (1995) Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 181:1255-1259 Yano S, Komine M, Fujimoto M, Okochi H, Tamaki K (2003) Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT. Biochem Biophys Res Commun 301:841-850 Zheng XX, Sanchez-Fueyo A, Sho M, Domenig C, Sayegh MH, Strom TB (2003) Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19:503-514

Arthritis Joint Pain

Arthritis Joint Pain

Arthritis is a general term which is commonly associated with a number of painful conditions affecting the joints and bones. The term arthritis literally translates to joint inflammation.

Get My Free Ebook


Post a comment